Trusting Her Voices: Trusting My Own

There was something different about this seven-year-old who at such a tender age had already lost her father. And if that adversity was not enough, Christine was struggling to fit in and keep up. Yet, there was something about this lost and lonely girl, some palpable sense I had of her resilience. After a psychoeducational evaluation, carefully chosen recommendations, and consultation with her mother, it would be 15 years before I next saw this girl. She was now a woman who was, perhaps not unsurprisingly, still struggling to fit in and keep up, this time with a far-less accepting college crowd and the rigors of an academic curriculum that was really of little interest to her.

I was immediately struck by how she was at the same time both young for her age and an old soul- isolated, enigmatic. In her “backpack of wonders,” as I silently called it, she had a number of amulets drawn from characters of popular culture; wore T-shirts advertising her fascination with or perhaps identification with popular teen icons, and soon revealed to me that she had learned to populate the empty rooms of her life with what she called her ‘All-Girls Group.’ “Voices in her head, damn!”, I thought to myself. Could I have so badly wanted to see that struggling child in the most benign light all those years ago, denying the possibility of early onset schizophrenia? A rising sense of panic muddled my thoughts. Critical, self-questioning voices.

What to do? Query her mother more deeply? Do a thorough psychological evaluation? Refer her immediately to a psychiatrist? Consider the possibility of hospitalization? These were the voices in my head, and while I did not ignore them, I addressed each of them, ruled out immediate danger, and opened myself to Christine’s inner world. In the process, I got to know Laura, a “real” young woman who chronicled her lifelong battle with cystic fibrosis in the book Breathing for a Living. I met Lisa, the take-no-prisoners character from Susanna Kaysen's Girl, Interrupted. And after being granted membership as the “only boy” in Christine’s exclusive private club, went to work with her, following her lead, suspending my voices, getting to know hers, and following her lead in trying to plot a therapeutic path for us and for her.

That phase of therapy ended abruptly following a surgical procedure for Christine and loss of the family dog, which I imagine were very destabilizing for her. I later found out that she had joined the Army. “Of all places to go… They will eat her alive.” When she arrived several years later to reconnect and reinitiate our work, I found out that Christine’s group had abandoned her to the military thinking it the wrong decision. But with some creative re-framing, she accepted the notion that her support team thought the Army would be an important test for her and that she had to go it alone.

And, as to be expected, Christine experienced considerable adversity during her short stay with Uncle Sam-a belligerent drill instructor, unaccepting platoon-mates, brutal physical rigors and loneliness Broken and alone, Christine hobbled back into her life and somehow her “girls” found her, flocked to her side, lifted her on their backs and marched her back to school…and life. Along the way, their numbers increased to include a few new select members, this time a few male figures- all strong, all supportive, all with stories of survival and resilience, just what she needed.

Christine finished her college degree, tried a few different jobs in the computer field, and as of this writing, was still searching for the very same things she was looking for when I first met her as a child. I see her whenever she calls, trust that she is never alone, and long since separated myself out from the voices in my head that did not trust the voices in hers. I don’t believe that Christine ever dis-trusted her voices – that was me, although I never showed it to her. I think I was only able to accept hers when I was finally able to subdue my own.
 

The One Thing a Therapist Should Never Say to a Client

As a graduate student I was given the old stand-by assignment: seek out an accomplished therapist and interview him or her. Since my overwhelming desire in life was to become a private practice therapist myself, I didn't envision this as just an assignment, but rather an exciting adventure. I was going to put my whole heart and soul into it.

Since I wanted to pick a person of note, I spoke to a cadre of folks in the field, including my esteemed professors, and decided on a therapist I’ll call Mindy. She seemed to be a real therapist's therapist. A large private practice? You bet. A superb reputation? Affirmative. A mental health conference presenter? Check. She even ran workshops around the globe in remote countries I had never heard of. This was going to be great.

Mindy’s administrative assistant was kind enough to set me up with the necessary appointment and it was off to the races. Her office was in the high-rent district in a city about 130 miles away from my hometown in St. Louis, but I knew the long drive was well worth it. As the elevator to her office sped from floor to floor, I glanced in the mirror to check my hair a couple times. Okay, maybe it was more like a dozen or more times, but keep in mind I wanted to come off as a serious future professional. Maybe we would be working together in the same practice one day. Yes indeed, I had high hopes.

Mindy was dressed in a muumuu that made her look like she might be playing a part opposite Elvis the classic Blue Hawaii.

I had imagined I might see a couch or a rosewood desk with spit-shined brass handles, but that was hardly the case. She motioned for me to have a seat while she sat down in an antique rocking chair.
We were separated by an unusually large sheet of paper like one might use in a lecture for a flip chart. But the paper was on the floor. Hmm, what was that about?

Before I could get my first question in which was something like "Did you know you wanted to become a therapist as a child?", she began firing questions at me.

I was way too timid at the time to ask this exalted expert what in the world was going on here, so I answered perhaps five or six questions. As I spoke, she would lean forward in her rocker and scribble something on the massive sheet of paper on the floor using a King Kong- sized marker.

Wait a moment. We weren't here to therapize me, or were we?

After just minutes, I tried to talk and she said, "Howard stop. I know exactly what your problem is."
Wait, I didn't know we were talking about my problems.

"I know you came here to interview me for your graduate class, but we need to deal with some much more important issues. You are just like me. You have severe anger problems and you are a quitter. Yes, a quitter. I am sorry to say you will never finish your master's degree. I'm going to set you up for a few sessions of individual as well as group psychotherapy. You still won't ever get your master's degree, but I can help you in other ways."

Had this merely been a bad dream we could have analyzed it, but it wasn't. I hadn't recalled saying anything even remotely related to anger and certainly nothing about giving up on graduate school. For gosh sakes, it was the number one thing in my life at the time.

Now fast forward to the present. I did an internet search and low and behold I discovered that Mindy never finished her degree. But wait. It gets even more interesting. Since she was attending a doctorate in psychology program where the master's was not conferred until you completed the doctorate, to this day she still possesses just a bachelor's degree in psychology. She was only allowed to practice back in the day when I saw here because licensing had not yet been enacted in our state.

So, what's the take home message? Well, I believe the behaviorist, hypnosis expert, and assertiveness training pioneer Andrew Salter (a famous therapist himself with just a bachelor's degree) nailed it when he gave the best definition I have ever heard of reaction formation: "You think you are looking out a window, but you are really looking in a mirror."

The worst thing a therapist can do? Well it is as simple as looking in a mirror while convincing yourself you are gazing out the window and making a pernicious statement about why the person sitting in front of the desk, or rocker will never be able to do something.

Oh, and by the way, Mindy, if you happen to be reading this blog and decide to email me to express your anger or discontent, just for the record, it's Dr. Rosenthal now.
 

Jose Rey on Psychotropic Medications: A Primer for Psychotherapists

Lawrence Rubin:  I recently had the pleasure of attending your lecture on psychotropic drugs at Nova Southeastern University in Fort Lauderdale where you are a pharmacologist and professor of pharmacy practice. I was impressed not only with your seeming encyclopedic knowledge, but also by your enthusiasm and understanding of the social, political, financial, and historical issues related to psychotropic drugs.

Therapists are not typically trained in the use of psychotropic medication beyond a graduate course or CE workshop or two, and even then, the training may be done by a representative of a pharmaceutical company. Beyond that, we may read articles in a journal or hear a story about these medications in the popular press, or learn from our clients what has worked and what hasn’t. At times we even hear horror stories about their misuse. With these things in mind, what would you say are some of the basic guidelines that therapists can follow when a client asks questions such as “should I consider medication for my anxiety, depression, or mood swings?” 

Give Psychotherapy a Chance

Jose Rey: That's an excellent question. I still would like to think that areas like mild to moderate anxiety and depression are very responsive to psychotherapy, and so that question would ideally come in the middle or late stages of treatment where frustration may have set in and therapeutic response is not occurring.
We should really give psychotherapy it's best chance to work first.
We should really give psychotherapy it's best chance to work first.

Medication might give us a little bit of a faster response, but it doesn’t seal the effect the way psychotherapy can. What I mean by seal the effect is that a drug doesn’t teach you anything. If you're taking a Xanax for anxiety and if you're so anxious and so distraught that you can't engage in therapy, well then by all means use something that helps you get into the room. But if you are only taking Xanax every day for your anxiety, for instance, then what have you learned about the cause of your anxiety? What have you learned about any coping mechanisms or other areas or ways to deal with the anxiety other than the behavior of popping a pill. I don’t like drugs alone, I prefer psychotherapy with medications.

Medications also are not curing anybody, they are tools. If you go with evidence-based medicine, you really don’t have a lot of great long-term information regarding the use of these medications. Yes, we know they can work in limited four to 12 week trials, but we really don’t always follow patients for 12 months or 24 months after treatment ends. And therefore, I think that using these agents up front to help a patient with more severe forms of anxiety or depression to engage in therapy is the best place for it, but you have to gauge the severity of the illness. Someone who is having the occasional anxiety attack should not be taking a Xanax or a Prozac every day. If you're having debilitating anxiety so that you can't engage in social or occupational activities, then you're already at a moderate to severe level in my book, and therefore the idea of pharmacotherapy seems attractive.

Our medications manage symptoms…but they don’t generally treat underlying issues.
I just don’t want to think of all of us as just bags of chemicals and that a new chemical like a Prozac, Xanax, Paxil or Buspar will somehow correct an underlying problem. Our medications manage symptoms. They do it very well, but they don’t generally treat underlying issues. Even if the underlying issue is biological like genetics, these drugs aren’t going to correct your genetics. You're always going to have that genetic aspect of the illness. They can only change the chemical availability of a neurotransmitter like serotonin, but even that wears off over time. And now we're back to where we started from.

Sometimes, these medications only work for a few months or a short period of time, and then your body finds a way to become tolerant to them. One of the smartest things I heard from a psychotherapist years and years ago about a person who was breaking through their antidepressants was, “if the brain wants to be depressed, it will find a way to be depressed.” And therefore, we can use multiple antidepressants with this individual, but they find a way to overcome them. And that does speak well to genetics and the other aspects of depression such as our view on the world and our expectations of the world. I don’t like to think that drugs can insert thoughts. Therefore, they can help our sleep or our level of anxiety but they won't teach us anything. 
LR: Just as a side note, does the research on the medication efficacy consider psychotherapy in the process?
JR: No, not at the point when you’re in phase one through three or in premarketing stages of drug development. It is extremely odd to see a drug go head to head with therapy. Historically speaking, for mild to moderate depression, psychotherapy and pharmacotherapy did very well. You only might see a separation for pharmacotherapy doing a little bit better than psychotherapy in the most severe cases. But in one of our best antidepressant trials, the STAR*D trial which was published more than 15 years ago, everybody had been given Citalopram, the drug Celexa. If they had done poorly on Celexa then they were then randomized to receive other treatments to see if they failed on one drug would they have a preferential response to the next drug. And in that case, they went from Celexa to Zoloft, Celexa to Wellbutrin, Celexa to Effexor, and there was a fourth arm, Celexa to cognitive therapy. And in all four of those arms, they had the same outcome, about 25 percent of the patients.
LR: Even with the cognitive therapy?
JR: Cognitive therapy did as well as any of those three antidepressants in achieving remission. And it was just fantastic to see that because we could argue that they had already failed Celexa, and even though they now met criteria for adding an antipsychotic,
cognitive therapy did as well as any of our medications.
cognitive therapy did as well as any of our medications.

Guiding the Prescriber

LR: Are you saying that because research suggests that a combination of medication and psychotherapy is a powerful tool, we must also consider where the person is in the trajectory of their symptomatology? So much so that medication may be useful upfront if they come in with severe symptomatology, and then we can back off a little bit and focus on the psychotherapy more. And there may be a need to revisit the medication at different points, depending on the severity, almost inserted as needed for a trial or period of time?
JR: I like that. That's a more concise way of saying what I was alluding to especially, when it comes to those periods where there might be more stress. Again, we're back to something like benzodiazepines like valium or Xanax. They're great on an as-needed basis, i.e. I need the effect to happen in 20 minutes or I need it to happen in 30 minutes,
but I don’t want the individual to take the medication every day in an almost avoidance behavior and not engage with that anxiety.
but I don’t want the individual to take the medication every day in an almost avoidance behavior and not engage with that anxiety. I prefer that benzodiazepines, for instance, be used only sparingly on a PRN bases and not on a regular daily basis.
LR: Perhaps the therapist can help the client develop a healthy relationship with medication and find a way to use the medication sparingly, but more intensely when necessary. Is the psychotherapist’s role in that venue right there, to help the client discuss their relationship with the medication, or is that more the province of the prescriber?
JR: That's a very good way to look at it or to ask that particular question, because I would like to think that the physicians would have that conversation with their patients.
LR: You would hope.
JR: But I don’t think they do. Most physicians these days are not engaging in any form of psychotherapy beyond 10, 15 minutes a session. Hopefully they are preparing the patient for medications, maybe what to expect including side effects and positive and/or negative types of outcomes. But they are probably not addressing these questions of how long will we be using this medication, when will we be using this medication, what does this medication represent? It should represent a tool and something to assist in the treatment outcome. But if you say a drug is all you need, then you're saying your problem is almost all biological. And let’s face it, it's not that.
LR: How can we best collaborate with the medical prescriber in the real world of clinical practice? 
JR: Some psychologists or some therapists may overstep the boundary and say, “I recommend we use this particular drug.” And the prescriber will almost immediately say, “you didn't go to medical school,” or “you didn't do this, and that sort of thing.” I wouldn’t approach it like that. I would approach it as “there are some aspects of our therapy sessions that make me think that along with the trauma that they may have gone through or the family issues that may be going on, they have some symptoms that might be very responsive to pharmacotherapy.”

The therapist can be recommending pharmacotherapy without a specific drug. But I think if the therapist could give [the prescriber] a list of the target symptoms, then that should guide their prescribing. Sometimes we lose sight of the fact that we're managing symptoms most of the time anyway. We could say for example that the patient is having this specific type of insomnia which is dominated by anxiety. The prescriber is then given a better assessment of the patient’s symptoms because it's hard for them to pick up on all the symptoms with a five or ten minute interaction with the patient.

There are primary and secondary selection criteria for a drug such as a psychotropic, and one of our primary selection criteria should be matching the patient’s clinical presentations to the other aspects of the drug, maybe its side effect profile. If the person is having insomnia, I might pick a sedating antidepressant. I have 30 antidepressants to choose from so why not pick a sedating antidepressant with a side effect that can have a therapeutic benefit to the patient. And therefore, instead of waiting four, six, or eight weeks for an antidepressant to kick in – when I match the side effects like sedation to an insomnia symptom of the patient, then that patient can sleep better today and tomorrow and they don’t have to wait a month to start sleeping better. When that therapist can give me the target symptoms that the patient is experiencing, that should guide the choice of the antidepressant. 

Speaking Their Language

LR: Many therapists may not work with prescribers or know how to find their way to prescribers other than through word of mouth. Can you offer a few tips for psychotherapists to help their patients find prescribers and what a therapist could recommend that their patient should look for in a prescriber? 
JR: It depends on the age of the patient. As I review the medical literature, I remember geriatrics. I know a good prescriber is someone who will stop a medication before they start a new one. Many of our patients have had multiple prescribers and have accumulated medications or accumulated disease states.
LR: Interesting. But how open will a prescriber be to a therapist who needs to know this information?
JR: That's hard to find. I won't say it's a unicorn, but it's a pretty rare situation. Of course, your patients are going to have to look at their insurance list.

Many of our physicians are specialized and they're very good at what they do, but I get worried about general practitioners, family practitioners and internists prescribing psychotropic medications because they weren’t specifically trained in that area. And unfortunately, but maybe fortunately depending on which insurance company you're talking to, they are the gatekeepers. A majority of our psychotropic medications are prescribed by non-psychiatrists and non-neurologists. They're prescribed by general practitioners and that is the system that we've developed.
LR: It sounds like psychotherapists really have to do their homework not only on prescribers but on what makes for good prescription practice. Elderly patients don’t clear medications quickly and there is potential for buildup and bad medication synergy.
JR: It is a very difficult situation when a patient is experiencing a problem due to accumulation and approaching levels of drug toxicity. It may be a non-psych drug, maybe a medical medication that they're not clearing either, but their presenting symptoms might look like depression or anxiety.
LR: You make it sound like psychotherapists really need to be savvy about medications, complications, side effects, medical illnesses, and the medications which may lead to pseudo- psychiatric symptoms. Therapists don't have the luxury of not being informed.
JR: If they're not going to become experts at pharmacotherapy, then at least maybe some psychotherapists could learn more medical terminology. If you're going to have a meaningful conversation with a prescriber, then use the same terminology that they're going to use. You can go online and take a course on medical terminology. At least when you're having conversations with those prescribers, you're better informed on the language.
LR: Not that we're trying to curry favor with prescribers, but at least if we're attempting to speak their language, and they're of course attempting to speak ours, then there's a better collaborative effort for the patient.
JR: Even courses in basic anatomy and physiology.
Let the therapist take it upon themselves to learn something about the medical world, as the medical world needs to take it upon themselves to learn more about the psychotherapeutic world.
Let the therapist take it upon themselves to learn something about the medical world, as the medical world needs to take it upon themselves to learn more about the psychotherapeutic world.

A Place for Medications

LR: In your workshop, you said something about targeting diseases versus targeting symptoms. And now it makes more sense to me because if I'm hearing you correctly, depression has a trajectory. It may be time-limited, it may not be. It may be exacerbated and will have peaks and valleys. But if a particular depressed patient is experiencing significant insomnia at point A, then the prescription of a psychotropic that also assists with sleep might take a chunk out of the depression.
JR: Exactly.
LR: Or if their behavior is interfering with their appetite, a certain other antidepressant may stimulate the appetite.
JR: Stimulate the appetite or reduce the appetite.
LR: It's looking at the disease as having its own life in a sense, and how can we help the person by optimizing their functioning even when they're depressed or anxious. 
JR: Exactly.
LR: Even with someone in the throes of bipolar disorder or schizophrenia, we can help the prescriber by feeding them information about targeted symptoms and then work collaboratively to optimize the person’s functioning, even though, for example, it may not change their cognition or impact their executive functioning.
JR: Sure, especially with schizophrenia and bipolar disorder and other severe forms of mental illness, where it's an issue of whether the medications are managing symptoms. But we're back to an individual suffering from schizophrenia or having to deal with those issues, and they may not even be able to engage in therapy or even educational or occupational interventions until their level of paranoia or hostility or insomnia has been addressed. And so these medications manage symptoms so that the person can then achieve a level of functioning that will allow them to engage in other activities.
LR: Are there some psychiatric or behavioral conditions where you’ll want to refer for a medical evaluation right from the start? I mean someone who is blatantly psychotic is not going to come to see you. You may find your way to them in an emergency room but you're not going to see them on an outpatient basis.
JR: That's a great example. Let me give you a hypothetical, but a very common case. Let’s say that we are dealing with therapy and the therapist is doing everything right. Their therapeutic relationship has been established and the patient is coming to see them. They're doing the work, they seem to be engaged in therapy, but they are not fully responding.
LR: Improving, but not optimal.
JR:  Exactly. Now let’s say that despite the therapy, the patient is still very anergic, they're sleeping a lot, have no energy and a lot of fatigue. This therapist might actually be obligated to refer the patient for a medical workup because all the therapy in the world won't reverse hypothyroidism. It's a relatively common medical condition where the first presenting symptom is depression, but not including negative cognitive thought, just the physical manifestations.

When therapists are feeling that they’ve hit a wall, that therapy is no longer benefiting the patient or you're doing everything right and nothing is improving, well then yes let’s refer. Let’s work out anemia. Let’s work out hormonal dysfunction, whether it's hypothyroidism or low testosterone or estrogen occurrences. Maybe we're getting the person in the very beginnings of a perimenopausal state and hormones are changing but the person is feeling anxious. They don’t recognize anxiety as anxiety. They recognize sweating, palpitations and hot flashes. This is a great area where the therapist should say the target symptoms could be medical conditions. I think it does behoove a therapist to have more than a passing acquaintance with medical conditions that could present with symptoms of depression and anxiety. 
LR: We need to pay attention to those subsections in the DSM that talk about medical conditions because those should be on our checklists.
JR: Absolutely.
LR: In the DSM-IV there were the decisions trees and the first two categories were medical conditions and substance abuse. Are you saying that we should be very cognizant about some of those medical conditions that are likely to have psychiatric sequelae?
JR: Absolutely.
In an ideal world, every patient who is getting therapy should probably be medically cleared.
In an ideal world, every patient who is getting therapy should probably be medically cleared.  If they're not being seen on a regular basis by a physician then yes, I would love for things like hypothyroidism to be ruled out early so we don’t waste a lot of time engaging in certain activities when all they needed was some Synthroid or hormonal replacement.
LR: A testosterone shot!
JR: I had a case presented to me just a couple of weeks ago where this person was dealing with a lot of depression and anxiety. They also suffered from migraine headaches but sleep apnea was an issue. And really one of the roles of the therapist is to help the patient recognize their conditions that need to be addressed, and even use something as simple as motivational interviewing to get them to use a CPAP machines or to more be adherent to their medications. If we can address these medical conditions, their secondary depressive and anxious symptoms will be addressed as well. If you have sleep apnea and you're not sleeping well, you're fatigued during the day. You're not concentrating during the daytime. You're checking off a list of DSM criteria for depression but you may have sleep apnea.
LR: You said something which hit me paradoxically, that perhaps one facet of psychotherapy, from a motivational interviewing perspective, is that it can help the person develop a healthier relationship with all of their medications. I can see that being a challenge. If the clinician is not generally supportive of medication but is open to its utility on a limited basis, then they can use their therapeutic skills to help the person use the medication more optimally. It would be analogous to helping a client who was resistant to using cancer drugs or thyroid drugs.
JR: Absolutely.
Every time we take a pill, no matter what the condition is, we are at least briefly reminded of why we have to take that pill.
Every time we take a pill, no matter what the condition is, we are at least briefly reminded of why we have to take that pill. And sometimes the patient doesn’t want to be reminded that they have a medical condition.
LR: Or a psychiatric one.
JR: Exactly. Schizophrenia, bipolar disorder, depression, every day you take that pill, that Lithium or that Prozac or that Risperdal or that Haldol, and you're reminded of the problem. That is actually a barrier to adherence. If you don’t want to be reminded of your conditions every day, a good way to avoid it is to simply not take your medications.

Everything Old is New Again

LR: What do you think is important for practicing therapists to know about the rapidly changing field of psychopharmacology? For example, SSRIs were once seen as the great hope but there has been some recent research suggesting the addictive potential of SSRIs.
JR: Well, I think every therapist should engage in whatever continuing education that they can to try to stay on top of it. Our current and future therapies are still not offering cures, they are managing symptoms. If the patient stops taking these medications we see high relapse rates. We have not discovered a cure coming down the pike. Everybody wants the magic pill. And this is where I think a lot of our patients might engage in illicit drug use or using prescription drugs from somebody else off-label and without a proper indication. Everybody is looking for that but it's not going to happen for us anytime soon.

We are expanding the pharmacology so that the newer drugs that are coming in the pipeline are going to be working a little bit differently from our current medications. That makes for interesting and hopeful expectations regarding their efficacy, but they're not going to be changing the landscape in any significant way. You had mentioned SSRI’s, which were never shown to be superior to our older tricyclics or monoamine oxidase inhibitors. They were safer but not superior in efficacy. The newer SNRI’s [selective norepinephrine reuptake inhibitors] or our other antidepressants that have come out in the last few years are still working on serotonin and norepinephrine. We might be coming out with different medications, but we're still locked into a very simplified view of the problem.

That's what I love about psychiatry and depression, schizophrenia, bipolar disorder, no two patients are alike. We are different genetically and experientially; everything that makes us who we are makes us different. And therefore,
we can't just apply one drug to treat all problems.
we can't just apply one drug to treat all problems. We reach this wall where two out of three people get better meaning that a lot of our patients are still partial responders or resistant. And that is the research ground for our newer medications; trying to treat SSRI partial responders, the patients taking Prozac or Paxil who have gotten better but haves not achieved remission. Or our threshold can change for adding an antipsychotic to the patient’s medication list like Rexulti that you see advertised on TV. As an adjunct to an SSRI or SNRI partial responder, we can ideally achieve a greater level of symptom reduction.

It's interesting that if we were having this conversation in the ‘70s, and ‘80s, and ’90s, we wouldn’t have added antipsychotics. One of my favorite antidepressants is a drug called Amoxapine. It is kind of in the tricyclic group although it's a tetracyclic and it's a serotonin and norepinephrine reuptake inhibitor. It has some serotonin receptor antagonism as well. But one thing that everybody remembers about Amoxapine was that it was the antidepressant with EPS (extrapyramidal symptoms). It had a little bit of dopamine blockade because it was derived from an antipsychotic. And we said, “oh no,” I don’t want to use Amoxapine because it might cause EPS.” And now our threshold for that has changed because all of our drugs that are FDA approved for resistant or refractory depression have the ability to cause extrapyramidal symptoms because they all belong to the atypical antipsychotic class. 
LR: Back where we were.
JR: I think it's just very interesting that even some of our older drugs had the qualities then, and we found a way not to like them. And now 20, 30 years later, we're back to combining then in treatment for depression.

Enhancing Normal


LR: Everything old is new again.

Changing direction for a moment, could you share your thoughts on cosmetic psychopharmacology which some of our audience may not be that familiar with?
 
JR: Okay, now that's a bit of a soapbox for me. Cosmetic psychopharmacology as I define it and how it has been defined by others in other cases like cosmetic neurology or neuropharmacology, is using medications to enhance normal. Let’s not talk about pathology and medications that were created to either treat it or prevent it, but now let’s take whatever definition you want for normal and enhance that. We've been using cosmetic pharmacology for a great number of years. We used amphetamines in World War I and World War II allowing a soldier or pilot to stay awake longer than normal. The soldier or the pilot did not have pathology, but we gave them amphetamines. And we still do this today, by the way.
LR: Students?
JR: Students are a great example of using the Adderalls and the Ritalins. We all drink coffee when we, study which is cosmetic pharmacology. I have a problem with the excessive use of cosmetic pharmacology in certain areas. I worry about teenagers in high school and about the college students using Adderall and Ritalin; thinking and believing, an urban myth by the way, that it will enhance their grades or their test performance. That has not been proven because every medication becomes the means of getting a better grade and then they believe that “this gives me a better grade so I will take it for this test. But I need to make a good grade in this class, so every test matters. I need to make a very good grade in all of my classes, so every class matters.”

Every test including the MCATs, PCATs or some GRE becomes a high stakes exam. And now what we thought might have been occasional one time, as-needed medication use becomes weekly, if not daily, use of these medications over the course of high school, undergraduate, and graduate school. Some of our children and young adults might be taking these medications for a period of at least eight to twelve years. And I don't know what's going to happen to their brain because your brain isn't done cooking until you're about 25-years-old, so there is still neuro-development going on.
And I think it's interesting how some individuals have rationalized the use of stimulants for brain enhancement
And I think it's interesting how some individuals have rationalized the use of stimulants for brain enhancement for lack of a better word. Now, every time a professional athlete trying to make money, trying to win an award, using maybe some steroids or using some oxygen enhancement drug is getting an asterisk put on their names.

If you have the most home runs and you did an anabolic steroid designed to enhance muscle performance whether it's strength or conditioning, why is it that we have somehow criminalized the use of steroids for muscle performance, but we are not criminalizing the use of the stimulants for brain performance? 

Medicating Children

LR: When you have a kid graduating high school with a 6.2 GPA who has been on stimulants since they were six, perhaps their diplomas should have an asterisk.

Since we’re on this topic, I would like to talk about psychopharmacology for children. I was speaking the other day with psychiatrist Allen Frances who chaired the DSM-IV task force and who later criticized the DSM-5 particularly for its invention of the diagnosis of disruptive mood dysregulation disorder, or childhood bipolar disorder. He believes that this diagnosis justified the use of powerful medication for children for what amounted to tantrums. And then you have parents and teachers pushing for medications for young children for conditions like ADHD. 
JR: I worry that sometimes we're requesting medication for symptoms that could be easily managed behaviorally or through psychotherapy. I worry about the snowball effect in child psychopharmacology. I will refer to the typical ADHD child as Timmy. Little Timmy has developed or has demonstrated some symptoms of ADD or ADHD and someone prescribes Adderall or Ritalin or some other stimulant. Now Timmy is highly activated because those symptoms may not have been true symptoms of ADD or ADHD. Add to that that our teachers have a fairly low threshold and they want a perfect classroom. You can't deviate from the norm very often in a large classroom setting. Timmy is now looking highly agitated, revved up, a little manic and now we're having to give him something at night to help him sleep or to bring him down. I use the term that we're “speedballing” little Timmy or he won't eat and won't sleep.

And now the drug that we give him to help bring him down brings him too far down and now someone entertains the idea of depression. Little Timmy is now getting an antidepressant along with a stimulant and some kind of medication that would reduce the neurotransmitters, these newer agents like Guanfacine, Clonidine or an atypical antipsychotic also approved for children with bipolar disorders. Our prescribers can rationalize that they're approved for use in these children. Follow me here! You’ve started with a stimulant, you end it possibly with an antipsychotic or neurotransmitter decreasing agent which looks like a downer. The downer results in someone saying depression and now we're back to an antidepressant. Timmy is now on three drugs, but drug number two and three could have only been in response to the side effects generated by drug number one which may not have been necessary. Our threshold for using, what I think are powerful medications in 5, and 6 and 7-year-olds is both impressive and sad at the same time. We really aren’t wanting to invest as much time in the therapy and the behavioral modification options. It takes work.
Our threshold for using…powerful medications in 5, and 6 and 7-year-olds is both impressive and sad at the same time.
LR: The implication for the child therapists is that they really have to be very aware of what medications the child is on.
JR: Absolutely. And the side effects that those drugs cause might look like other therapeutic issues to be addressed.

Psychotropic Drug Dependence

LR: And help coach parents to ask better questions to the prescriber or help them not to over-rely on the pediatrician for a prescription of psychotropic medication even though it's easily done.

In a similar vein, psychotherapists often work with patients who have substance abuse problems and are typically trained to recognize not only the physical signs but also the psychological, social and behavioral symptoms. Can you think of a checklist of symptoms and/or signs a psychotherapist might consider for a patient whom she thinks is having a problem managing their psychotropic medications? 
JR: Oh, that's a very good question. Well, it depends on the psychotropic medication. For argument’s sake, let’s say a person has been prescribed Xanax and told to take it only as needed in more extreme situations of stress and anxiety. If they are refilling their prescription every 30 days as if they are using it and consuming it on a regular basis, then this sends a message to the therapist, as it should to the prescriber, that this person is having anxiety every day to the point to where either they are taking their medications even when they don’t need it to avoid anxiety, or their level of response is not where we want it to be, or physical dependence has set in.
Physical dependence on a drug like Xanax probably sets in as early or earlier than even addiction.
Physical dependence on a drug like Xanax probably sets in as early or earlier than even addiction. The reason why that is – and this is why I think benzodiazepines can be a trap for a lot of our patients, is that if I give you a benzodiazepine like a Xanax or an Ativan or a Valium for longer than two to four weeks, then when you don’t take the medication, the first symptoms that occur are anxiety and insomnia which are the very reasons why they were prescribed in the first place. Their continued use is reinforced and if this person is now having to take their medications on a regular basis and that was never the treatment plan, then you're looking at the signs of at least physical dependence.

Here’s an example. Grandma might have lost Grandpa 15 years ago. It was unfortunate and it was sad and she was having grief and couldn’t sleep. They gave her some medication for sleep or they gave her some medication for anxiety during the day. And 15 years later, she’s still taking that medication, way beyond the grief reaction time frame. Someone says to Grandma: “you know what I think, it's time that you stop taking the Halcion or the Valium or the Xanax.” First, she has a regular anxious reaction but then says, “you know what, you're a healthcare professional”, or “my daughter said something, so I will stop taking that medication as you recommend.”

That first night is the worst night of her life. It is insomnia and anxiety and it sends the message to Grandma that “I still need the medication. I've got the same problem I had 15 years ago.” Physical dependence sets in nicely with some of these controlled substances that we have.

If a person is demonstrating an avoidance behavior to stopping their medication, then they're avoiding withdrawal symptoms. Now if they are drug seeking and more overt and they’re taking more than prescribed, I think those symptoms are a little bit easier to see for individuals trained in substance abuse and addiction. It's the avoidance of withdrawal symptoms that look like the psychopathology for which we started the medications in the first place. That's why Grandma gets in trouble. That's why she’s still taking Ambien 10 or 20 years later or Xanax that much later.

LR: It goes back to this idea that as psychotherapists who work in the province of the mind in this age of medication and era of the brain, we have to be so much more aware of the relationship between the behavioral, cognitive and emotional changes in our patients and the possibility of their drug using behavior, whether licit or illicit. 

Health Literacy

LR: In 1997, the FDA lessened restrictions on advertising pharmaceuticals including psychotropics directly to the public. One of the results has been that people make specific medication requests to their physicians. What are your thoughts on DTC (direct to consumer) advertising?
JR:
direct to consumer advertising…told them they were not alone.
At first blush, I don’t like it. Okay, let me qualify that. The appropriate answer is that direct to consumer advertising when it was approved did one good thing to a lot of our patients which was that it told them that they were not alone. A lot of individuals are in their psychopathology-depression and anxiety, and they might think they're the only ones who feel that way and that no one understands them. They might even be fearful of seeking out treatment. Direct to consumer advertising usually casts a wide net of symptoms such as anxiety, depression or mania so the individual says: “wow, it looks like there are other people out there with this problem.”
LR: It provides them with a sense of community.
JR: Right. It might reduce their reluctance to seek out treatment, which is good. However, telling you a very specific drug is the drug for you is not a good way to go. These newer drugs that are in direct to consumer advertising are sitting in the sample closet of every prescriber and the prescribers may be thinking, “I don’t want the patient to spend a lot of money.” They give their patient a sample box with a seven, ten, twelve or thirty-day supply for free.

If that drug works then great. However, that drug might cost $100 or $200 per month. And who’s going to pay for it? If that patient doesn’t have the financial resources or the insurance, then why did we just pick an expensive drug that they can't use beyond seven or fourteen days? Now we have to go to our generically available medications that aren’t advertised. For this reason, I don’t like direct to consumer advertising about a specific drug. I prefer for patients to tell me about a disease state and not mention the name of the drug. That's the better advertising. 
LR: It sounds like therapists almost have a moral obligation to engage their clients in conversations about psychotropics and advertising and to help them be the smart consumers of media. And to be diligent in their choosing of prescribers. In other words, helping psychotherapy clients beef up their courage to ask the hard questions, otherwise they're just going to be victimized by marketing, medicine and medication.
JR: Health literacy goes beyond learning about your own disease state and your disease state’s management. I think it goes into this area of being informed consumers, asking the right questions to the prescriber. And therapists can help their patients become health literate by referring them to the right resource, or at least helping them ask those questions. Now, granted, what have we asked for our therapists to do in the last hour? We've asked them to be well- informed through continuing education regarding pharmacotherapy, prescribing, laboratories and basic medical terminologies. We want that for their patients as well.
I really wish more of my patients would take responsibility for their disease state and its management.
I really wish more of my patients would take responsibility for their disease state and its management. The patient really is the center and one thing that we don’t do as often as we probably should is let the patient be part of the decision-making process. Not just a recipient but an active member of the treatment team. Because all our efforts will be for nothing if they don’t do their part of the treatment plan.

Wrapping Up

LR: As we wind down, can you offer advice for the psychotherapist just starting out who is not particularly cognizant or even desirous of learning about medications, or is maybe even anti- medication?
JR: Well, given that we should ideally all belong to some interprofessional collaborative practice, I think that a psychotherapist really needs to do their very best at keeping up to speed, going to educational programming, continuing psychopharmacology education, and learning medical terminology so that they can have meaningful conversations with other practitioners. When they are referring a patient who is seemingly resistant to psychotherapy and the depressive symptoms are continuing, they could say this might be hypothyroidism. At least then we can do the thyroid function test, at least we can do iron levels, at least we can do a complete blood cell count, to make sure that the patient doesn’t have a certain anemia.
LR: So not only build a lexicon but nurture their relationship with the field of medicine.
JR: Yes.
LR: I can almost ferret from what you're saying, there there’s a the need to include mandatory biennial psychopharmacology continuing education for licensed clinicians. In Florida we have mandatory CEs for ethics, domestic violence, and medical errors, so why not chew off an hour of that and make it mandatory training around psychotropics?
JR: Given our world of psychotherapy, I think that would be prudent-absolutely.

In Praise of the Life of a Psychotherapist

“Clients often ask me how I can stand listening to them drone, whine or complain.” Just yesterday someone said, “I’ll bet you need a stiff drink after listening to this stuff all day”. I can safely say after nearly 25 years in practice that I have never had this day that they seem to imagine—a long, tedious day of listening to self-pity and self-absorption. Particularly lately, what I feel is mostly gratitude. Somehow, I get to do this: come to work to listen to the stories of the intimate lives of others, to know and to love the hard-fought struggles of their lives, and to share and assist in their journeys toward healing, growth, and transformation. And what I have been thinking about a lot lately is how those journeys have in turn shaped my own journey in myriad positive ways. I know I am far from alone in my experience, and that my grateful thoughts could not begin to be comprehensive, but I think it is useful for us as psychotherapists in what is often a beleaguered world to remind ourselves of the many personal and psychological benefits of our chosen path, such as emotional maturity, unlimited opportunity for continuing education, learning about love, practicing mindfulness and self-awareness, accepting failure, and fostering resilience.

Emotional Maturity

For me, much of this feeling of gratitude is a happy by-product of maturity. When I was younger, I was so afraid of not being enough, or of doing something wrong, or of not being liked, that it was harder for me to stay focused on the great gift of being able to do this kind of work. As I have aged and grown in confidence, the energy I used to expend fussing about my own probable inadequacy no longer draws as much from my other resources. I am able much more easily to make myself fully available to another without such a weighty anchor of self-doubt and self-consciousness. Another reason for gratitude: I managed to find myself in one of the few fields of work where a few gray hairs and wrinkles, and the maturity that hopefully comes with them, is a benefit.

In turn, maturity seems also to be a by-product of the work. I have often thought that one of the reasons therapists are so often drawn to various forms of meditation is that mindfulness is an intrinsic aspect of the work of psychotherapy. Years of practice in itself create a habit of focused attention that is a growth-promoting emotional self-discipline. There is self-surrender in entering a session that I have come to welcome wholeheartedly. It is not as though I have ever completely and perfectly stayed attuned and present for every moment, but like mindfulness meditation, I and all of us who do this wander in our minds, draw ourselves back, wonder about the wandering—and return. Unless the stress of my own personal day is truly overwhelming, “listening to others helps me to move into a mindful space and draws me out of myself”. The constant practice of moving into this mode of being no matter how tired or irritated or stressed or sad I may be is a daily workout that leaves me stronger, more flexible, and more resilient in all aspects of my life.

Unlimited Continuing Education

Learning as a psychotherapist is a lifelong project. In seeking ways to help clients, I read and consult and attend workshops and, in the process, learn about myself and understand myself and them better. Often when a client is exploring an issue or attempting to create change it challenges me—because I want to feel my own integrity with them—to push to grow equally. I cannot suggest assertiveness without finding it within myself, ask clients to trust their own authority without trusting mine, or ask clients to challenge their own fears and avoidances without challenging my own. So many of my clients are or are learning to be brave, loving, compassionate, and skilled, among many other gifts, and I am grateful for the opportunity to share in and learn from their growth.

To give a recent example, I have been working with a woman who has been trying to cope with a serious illness, recent job loss, and a disintegrating marriage to a husband who is psychologically unravelling and will likely end up in prison, all while trying to keep life stable and sane for two small children. In the last few weeks, her home went into foreclosure and she had to get a restraining order against her husband. She came into a recent session not surprisingly sad and overwhelmed, but in the context of our conversation mentioned that she had gotten a journal so she could keep a daily record of all the things she is grateful for. She is worried with all that is happening in her life that her perception will become distorted if she doesn’t make an active effort to recall what is good and positive. Having never faced the kind of comprehensive disaster she is now confronting, I truly don’t know how well I would marshal my psychological and spiritual resources to meet it, but I know her example has added to whatever resources I will bring to bear to cope with whatever inevitable hurts arrive in my life. I hope I will be able to remember that in the face of enormous losses and challenges, it was clear to her that she needed to focus on successes, however small, on moments of beauty, and gestures of kindness and generosity. I am grateful that in a context where I am supposed to be the guide, I am also so often guided.

Love

As therapists, we are rightfully cautious about how we think about love in our work, but “I have come to feel that love is inevitably a part of any authentic caring relationship”, and therefore an inevitable part of most therapy. Love of course is a big word and can be used to describe a lot of different relationships, from one we have with chocolate to one we have with a lifetime companion. I mean the non-possessive, boundaried love that is often created within the unique intimacy of the therapy relationship.

Recently I participated in an exercise in meditation class that I believe is relatively common but was completely new and unexpected to me. We class members were led, eyes closed, to sit in two rows of chairs facing each other. When we opened our eyes, we were asked to look into the eyes of the person across from us with all the love and understanding in our hearts and to imagine that this face across from us was the face of the divine here on earth. I gazed into the beautiful brown eyes of the middle-aged man across from me, a total stranger recently arrived in the US from India, and saw myself reflected in them. Both of us teared up as we grasped each other’s sweaty hands. We were totally unknown to each other, but for those moments, intensely close. It was far from a perfectly transcendent moment—it is uncomfortable to stare at length into the eyes of a stranger, and I found myself worrying about the unattractiveness of my blotchy, tearstained face, or if he wanted me to let go of the hand I was inexplicably clutching like a lifeline—but I was powerfully moved, and shocked by my sense of recognition and awe. We were asked to close our eyes again and shifted our seats before opening our eyes to another, a different stranger, to whom we were to open our hearts in love and share that deep, long and reciprocal gaze. The message was a yogic one, about the divine that dwells in all of us if we choose to see it, but it also made me think about love in therapy, and how this exercise resembles in many ways what we do in our offices day and in and day out.

We ask another person to open themselves up, to sustain our gaze, and to trust that we will see them as gently and with as much acceptance as we can. When we add compassion, empathy, understanding, patience, respect—all the things we strive for in our stance as professionals—we also, at some level, will feel love. And I find that this makes me, on good days, look at the world and myself more gently, with more forgiveness. This is a lesson I want to learn, again and again—more so now, in a world that seems increasingly focused on hate and division.

Speaking about a therapist’s experience of love creates a lot of anxiety—I am a little anxious trying to write about it, knowing as I do the chorus of objections and concerns that arise about boundary violations or crossings if the love we experience is not managed safely or professionally. I have seen from the front row how love in a therapy relationship can be abused—I have clients who have had sex with prior therapists, been subject to other sorts of boundary crossings (too much information about the therapist’s personal life, coffee at Starbucks, stock tips, or non-standard payment arrangements to name a few), or have been bullied into behavioral changes that support the therapist’s ego and self-esteem rather than the client’s goals—and I am well aware the effects of even the smallest of these boundary violations are devastating to clients. Because love is such a charged and complicated word, I do not use it with clients, but not saying it does not mean I don’t feel it or have the need to make sense of the experience of it clinically, personally, and spiritually. And I believe that the non-possessive, boundaried intimacy of therapy relationships has taught me much about love, and I am a better human for practicing loving others in this way.

Mindfulness and Self-Awareness

For most of us, the most comfortable and familiar way to think about love or any other emotional experience centered on the dynamic relationship between therapist and client is as a transference/countertransference phenomenon. That involves a certain exercise in mindfulness, a capacity to be open and aware of one’s own experience and to think about and feel how that experience is a communication from and about the client—often a disowned or unmet need—and consider how to use that information in a healing, compassionate way. It is also an exercise in self-awareness, because our slates are not blank, and we have our own unruly psyches to manage. The experience of love (or hate, or any other emotion), however it is manifested, becomes an opportunity to feel without acting, to explore different narrative possibilities and feel them out for their truth and consistency or self-delusion and wishfulness, just to name a few possibilities. There is no real way to be fully engaged without feeling, but as therapists we learn to watch the feeling as we feel it. This capacity for mindful self-awareness is perhaps the Rosetta Stone of positive emotional functioning, the skill we try to teach our clients in every session, and the skill that determines our success in helping them heal. It has also, of course, made me happier and more effective in all my relationships.

Accepting Failure and Protecting Resilience

It is unpleasant to fail, and I don’t enjoy it, but my work as a therapist has given me a ton of practice, and I have learned to accept failures more gracefully, with less unproductive self-criticism and more and more balanced self-examination. I have gotten it wrong more times and in more ways than I can possibly count. Every day, every session. Today, eager to make my own point, I dragged a client who was really hurting onto a small tangent because of a thought that was interesting to me, but not at all his direction or focus. I stumbled back to really listening to him, but the diversion created a small but avoidable need for repair and re-attunement. And that was a good session, on a good day! “But constant practice helps me to keep my balance, not get overly focused on mistakes, and move on to attend to things that are really important.”

Often as therapists we focus on issues of burnout or secondary trauma, and certainly these issues are real, especially in settings where therapists have limited control or access to support. I am inclined to believe that much of the possible psychic damage is not about the actual work we do, but the environment we do it in. If we see too many patients, fail to maintain reasonable boundaries, do not have adequate opportunities for supervision or consultation, try to meet unreasonable expectations or fail to care for ourselves psychologically outside of sessions, we will suffer in our work—both in our ability to do it well and in our own psyches. Without these boundaries, we cannot foster and protect our own resilience. But in the presence of control and support, we sometimes forget to emphasize in much of our dialogue about life as a psychotherapist how very fortunate we are as therapists to be able to engage in work that is entirely about finding meaning and healing through relationship.

In Conclusion

I also feel a little bit of guilt about my good fortune. I am spoiled. People are hurt at all levels of society, but I am not in the trenches, and I deal less than many with the horribly complicating factors of socioeconomic stress. And those other huge structural issues—such as racism, sexism, and homophobia—are somewhat blunted for my largely educated and economically stable clients. I have a group practice with colleagues I love and respect, and whose intellectual and clinical growth has interwoven with mine for over almost 20 years. “It would be churlish not to be grateful for such fertile soil in which to grow.”

We are all aware of the downsides of our vocation: the pay is not great; although we have a lot of freedom, those of us in private practice do not have the practical benefits many professionals take for granted, such as sick or vacation days, or health insurance that is less than astronomical; we tend to be made fun of in the popular culture; we have limited job security; the importance of our work is undervalued, misunderstood, or misrepresented by many; if you do the work well, you will be no stranger to self-doubt and uncertainty; you have to metabolize a lot of ugly stuff; and new acquaintances tend to become uneasy when you tell them what you do, just to name a few. But the world is not rich with opportunities to make a living in ways that feel intellectually and morally coherent and also promote emotional health and growth. It is a life of service in many respects, but also a life of service to the self, an opportunity to try to do good and to try to be good. That is a lot to be grateful for. 

Finding Playfulness in the Seriousness

I have recently seen videos of social experiments that encouraged adults to find time to play. In one such video, a hopscotch board was drawn on a city street and over the course of the next ten hours of the 1,058 people who walked by, only 129 stopped, if but momentarily, to engage in the playful distraction.

In another video, a man and his friends set up a large ball pit in an urban space to see if adults would take a moment for themselves. He asked people walking by if they were too busy to have fun. Immediate responses focused on the need to return to work – all work, no play. However, several people decided to seize the moment to dive in. A man wearing a perfectly pressed suit threw his briefcase into the pit moments before jumping in. The joy that exuded from those playful moments was priceless.

I am a play therapist, so am fortunate to play for a living. Through play therapy, children can externalize, process, master their struggles and tame inner demons through a variety of expressive mediums. Sessions transform from battles to caring for babies, playing sports, building worlds in the sand, making and eating full course meals, watching puppet shows, drawing, painting, blowing bubbles, and much more. With play, the possibilities are only limited by one’s imagination. It is truly a privilege to see the healing power of play first hand and to make time to experience play myself.

I would guess a vast majority of adults believe that play is primarily reserved for children. Life is stressful and there are a plethora of serious tasks and obligations that we must save our energy for instead of goofing off and spending time playing. Many of us are inundated with a full caseload, meetings, case management, consultation groups or supervision, continuing education, family obligations, and other side projects. We simply do not have time to stop and play hopscotch or jump in the ball pit. It does not mean that we do not want to; there is just not enough time in the day.

Being a psychotherapist is an immensely rewarding, and at times challenging and emotionally draining job. Being a container for so many hurting humans takes its toll on mind and body. We need self-care more than we allow for ourselves. We need to remember that we cannot give so much to so many and very little to ourselves. We must be gentle with ourselves and find time to rest, relax, and replenish.

When was the last time you allowed yourself to be completely immersed in your imagination and fully experience that moment? How can you make more time for playful self-care? When an obligation needs to be removed from our schedules, why is self-care is often the first to go? Because we convince ourselves that we cannot possibly sacrifice anything else on our schedule. As the Zen proverb states, “You should sit in meditation for twenty minutes every day – unless you’re too busy. Then you should sit for an hour.” This gentle self-care reminder is applicable to time spent playing as well. Foster more moments of joy, laughter, happiness and the liberation play can bring in your lives. The next time we contemplate if we have time in our day to playfully tend to our minds and bodies because we are too jam-packed, we must remind ourselves that these are the moments that we need these experiences the most.
 

On Holding Your Tongue

We therapists have all been guilty of this one: holding forth when we should really be letting our client have the floor. I recall many cringe-worthy moments as a nervous new therapist, going as far as talking to my clients about the theory behind what they were experiencing, convinced they would be as fascinated by this as I was. Fortunately, I was empathic enough to pick up on their blank stares and restrain myself.

I am currently in the process of doing a qualitative study on the common factors in working with dreams. This is relevant because of what I’m finding in the data around dream interpretation. In short, don’t do it! What modern dreamwork methods suggest is that even if you have a jaw-droppingly brilliant sense of what your client’s dream is about… don't, especially if you have something amazing to say, the best thing to do is keep it to yourself!

Why hold back? There are a few good reasons. First, because we may not actually be right. Dreams are multi-faceted and only the dreamer really knows what they are about. My wonderful interpretation may fit the images tidily and still not have any relationship to the client’s dream. Also, I’ve found that if my take on the dream is not a fit, my less assertive clients will do their best to see my point of view and contort their dream into the Procrustean bed I’ve made for them.

Another reason to hold back my brilliance? This is the main reason: because if I don’t, I rob the client of their own thrill of discovery, the excitement that comes when they unlock the meaning of the dream for themselves. Not only will the client’s interpretation be better-timed because the realization comes when they are clearly ready to have it, but also, the insight or experiential shifts made in the process will stick because they are the dreamer’s own and there is strong emotion attached to their discovery.

Despite what I just wrote, on occasion, if I feel I really must offer my pearls of wisdom about a dream, I have learned to do so tentatively, and back off immediately if I get that telltale blank stare. I may be right, and the timing may be wrong. Or I may be way off base. Either way, the best interpretation is the one that comes from the client. After all, I don’t want them to walk away from therapy thinking, “Wow my therapist is so smart, how can I manage without her?” Rather better is when they walk away with a sense of mastery and confidence about their own ability to read into their dreams and their life.

That said, good dreamwork like good therapy, should be highly collaborative. We all tend to have huge blind spots around the images that come in our dreams; so playful and respectful curiosity can help guide the dreamer to find their way through the complexity of their dream world. You can also use a device from the dream interview method that suggests you play really dumb and ask the dreamer to explain their dream images as if you are from another planet. The words they use for me-from-Mars often give a sense of how the image may be a metaphor for something in their life-and what they say is never predictable. If they dream about a dog and I say, “I’m from Mars, what’s a dog?” the answers could range wildly: from a dangerous beast with big teeth to my best and most loyal friend.

In the common factors research into dreamwork, of the 14 dreamwork methods I analysed, only psychoanalysis still advocates for interpretation by the dreamworker. All the rest advise strictly against it and suggest instead to encourage the dreamer to engage with their dream experientially and allow the dreamer’s sense of what the dream means to emerge. When I’ve had the self-discipline to do that, so often I have been amazed by the creativity and insight from my clients, and the unexpected places they went with their dream images, that I’m glad I held my tongue. 

Shame Part 2: Shame Proneness

Megan came into session and sat down. Her eyes wandered around my face, but didn’t meet mine when she said, “I did it again. I went back to him.”

“Tell me,” I said, leaning forward.

“I’m a – a loser. I can’t stay away from him even though he’s bad for me.”

Megan had come into therapy after failing to sever ties with her most recent boyfriend, Tim, a man who repeatedly left her feeling emotionally abandoned and worthless. She reported a history of tumultuous intimate relationships that consistently left her feeling lonely and dissatisfied.

Tim was no different. Every time he dismissed her or invalidated her, it tore a little more of her heart out. Worse yet, it confirmed her inner fear: She was worthless and no one would ever, could ever love her. Trying to repair fractures to her self-esteem, she would search for the next man to love her, only to find herself in another relationship where she felt dismissed and worthless.

This isn’t unusual. It’s certainly a story I’ve heard variations of many times as a psychotherapist. Megan, who was thirty-five years old, reported that she had been going through this cycle since she was a teenager. She felt hopeless that she would ever find the stable, loving relationship she so wanted. I felt it as soon as we started our work together. Shame.

In my last blog post, I discussed the shame that entered the room in early sessions, when patients began exposing themselves. Megan’s shame was more complicated. Normal shame is transient, but for Megan, her inclination was to experience shame in all ambiguous situations. This proclivity has been assigned various names. I like to call it shame-proneness, which is the term June Price Tangney, one of the leaders in research on moral affects, (shame and guilt), named it.

When Megan came into situations that naturally elicited self-assessment, her emotional response would be feeling bad, small, defective. Self-esteem is a cognitive evaluation of the self; shame, on the other hand, is an affect, and therefore, permeates the entire self, spilling into every crack of someone’s being, coloring all their experience-darkly.

On some level, Megan believed that she deserved poor treatment from men, causing a repetition of the very pattern she was trying to stop. No matter how hard she tried to find a different outcome, she was always confronted with the same feelings of shame. Thus, the narrative – I am bad – that she desperately wanted to change, perpetuated itself.

Megan explained that she went back to Tim during the week when he promised it would be different, only to be left again. This was the fifth time she went back only to be left.

“He threw me out.” Tears trickled down her cheeks. “See, I’m weak. I’m a failure at everything. I’m never going to find what I want. It’s me.”

Her feeling bad about herself in the Tim situation pervaded other aspects of her life. That is, she felt bad all around, not just in relations to Tim.

I knew I had to help her see how her self-perception created a type of self-fulling prophecy. So, I reminded her of what we had been working on. “Remember what we talked about?” I often use psycho-education with patients, even when I’m working more psychoanalytically as I usually do with a shame-prone patient. I don’t find that keeping the nuances of therapeutic work undisclosed helps, especially for patients who feel so exposed already. It’s like throwing them outside in the cold without a coat, alone.

Megan and I had discussed shame. She knew that it tied back to early experiences of emotional neglect and abuse, where she unfortunately heard messages that she was bad and wouldn’t be anything different, ever.

“I remember, that just makes me feel worse. I should know better by now,” she whispered. This is where shame is so tricky; it’s very hard to intervene without evoking more shame.

I addressed her experience in the room. “We knew it would be hard not to go back if he called. Intellectual insight comes before the emotional connections that make change easier. You are working very hard to undo a narrative that took years to build. It takes time.” I leaned forward, again. “Remember, what we talked about last session, during the break from Tim.”

“Yes, I’ve – gosh, I can’t believe I forgot.” She pulled out her phone and showed me a schedule of all the workouts she had done the last week. Megan had been very athletic. I encouraged her to go back to exercising.

I wanted her to feel her strength and resilience. I wanted her to find her value in her activities. One of the most effective ways to help people combat these shame narratives is to help them access and activate their natural strengths, the parts of them that weren’t fostered, because no one acknowledged them when they were younger.

It’s our job as clinicians to discover these natural endowments and cultivate them for all of our patients. Shame-prone patients need more help figuring out what they are and more time to develop motivation.
Megan smiled as she showed me what she had accomplished that week. I saw pride glowing in her eyes. I observed it with her. “What are feeling?”

“I feel good.”

I smiled, thinking that we had found a space for Megan that was shame free. “What’s it like to feel good?”

“It’s something I knew I wanted to feel, but I could never quite find.”

“Now that you know what it feels like, it will start to get a little easier. Be hopeful.”

“I am.”

*Megan is an amalgamate of patients suffering from shame-proneness.
 

Shame Part 1: Walls are Fears Disguised as Safety

The wind blew in strong gusts, howling and shaking the windows. Tracey pulled her cardigan tighter, then rubbed her arms with her hands. “I hate strong wind. It feels like the walls are going to come down.”

Interesting, I thought, we’re getting closer. This described exactly what was happening in the room.
Tracey and I had been working together for four months but had barely scratched the surface. She discussed work-related stressors and dating. She would go into detail about the many men she dated, but she never described her feelings. I wanted to know more about her inner life, but I felt her guardedness. She had a wall up. And I had to respect it.

Walls are fears disguised as safety.

But why are they there in the first place? When patients come in, but have trouble disclosing, this is the question.

We call it defensive structure or defensive mechanisms or resistance, this wall. We have words, but one I rarely hear that is significant, is shame. My dissertation topic involved a thorough analysis of shame and I have continued my research. Every time I’ve presented on the topic, students and established clinicians alike ask the same question: “Why aren’t we having classes on shame?” It’s important.

Shame is the deepest and most painful affect, as it involves an evaluation of the entire self. Whereas guilt assesses what we do- “I shouldn’t have done that”, for example; shame evaluates the entire self: “I shouldn’t be that.” Guilt says, “what I did is bad.” Shame says, “I am bad.” Shame pervades our sense of self – entirely.
Shame also involves the real or imagined perception of another. It’s the reason why infants and toddlers will run around nude without feeling exposed. They haven’t reached the developmental stage where they recognize themselves in the eyes of others.

The essence of psychotherapy requires that patients come in and reveal their innermost self, layers of secrets, elaborate fantasies. We are asking them to tell us the very thoughts and feelings that are usually hidden, because we don’t want others to see. Shame inevitably arises as the bricks come down and the patient feels exposed.

For patients like Tracey who have never been in psychotherapy before, this is often even more difficult. Additionally, unresolved shame creates more psychotherapeutic challenges. Unresolved shame (which I will discuss in the next blog), develops when injuries to the self occur over and over; any type of emotional abuse will leave people with some unresolved shame, which is woven into the very fabric of their identity.
In a lecture I had given some time ago, a psychodynamic student asked if I thought it was our own shame that made us avoid discussions of shame. I hope not. We need to afford patients the luxury of a safe room, where we are sensitive and cognizant of the shame that naturally arises as disclosure increases.

I had to help Tracey feel safe enough to slowly remove the bricks she felt were loosening. I went with the metaphor. “What do you imagine would happen if the walls came down?”

“I dunno.” She crossed her arms tighter.

“Are you feeling that right now, like the walls are coming down?”

She diverted eye contact, picking at a string on her shirt. “I don’t want you to think I’m crazy. I feel crazy sometimes.”

I leaned forward. “I know this is hard. Everyone that comes in here feels like their thoughts are crazy. I have thoughts sometimes that others might think were crazy. It’s normal.”

She looked back at me. “You do? But you’re a doctor.”

“We all have ideas and thoughts and fantasies that feel bad or scare us sometimes.” Small self-disclosures to normalize the situation and show patients that we are also vulnerable to emotions helps ease shame-ridden angst. Also, keeping the dyad collaborative instead of hierarchal reduces shame.

“I have thoughts like that all the time.” She placed her hands over her face. “There are things that I’ve never told anyone before. I know I should tell you, but it’s very hard.”

“I know it is. Maybe we can start with what you’re afraid I will think.”

“OK,” she said with a small smile. I felt a few bricks had come down as I acknowledged her shame. I knew that the more we discussed her fear, the safer she would feel to explore what was behind the wall. It would be two bricks down, one back up, but at least we were finally at a start.

*Tracey is an amalgamated example of patients during early sessions struggling with shame. 

The Healer that is Hurting

Life’s a beach, or so I’m told. Paradoxically, death may draw many apt analogies from this image.

This summer, my work was humming along to the tune of vibrant pulsing music, much like a beloved beach getaway. My client load, lightened by family vacations, left breezy spaces in my schedule for unpacking course development and writing projects that had been tucked away for a while and for unfolding new ideas I had been eager to examine in the full light of day.

The sun shone brightly down as I played with the projects like beach volleyballs in the ocean, keeping each in the air with my respective co-teachers and co-authors until they skidded across the water before me with large splashes of inspiration, ready to be passed, set, and attacked in turn with greater intention.

And then, I woke up one morning this week to an email informing me that a buddy of mine who has been battling brain cancer for more than a year is now in end-of-life care. In cruel and rapid succession, thirty minutes later, I learned by telephone that my mother-in-law died peacefully in her sleep the night before, after her own two-year fight against cancer. Despite the battles my loved ones had been fighting, the news of these events was both sudden and unexpected, like going for that ball in the water and falling off the sandbar that I didn’t even know I was on into the depths of the ocean, scrambling to find solid footing again.

Anticipatory grief was launched from the American side, where my buddy is from, and was amplified by the full force of the shipwreck of my mother-in-law’s passing on the Swiss side, where I now live. It has been two and a half years since my last family loss, my maternal grandfather, my last grandparent. I remember that it hurt to lose him – an enormous, ocean-sized bucket full – but I had forgotten how ravaging grief feels in the moment it is felt. Until now.

Grief is often described as coming in waves. I had forgotten how bone crushing and soul squelching the break of those tsunami-sized waves feels until I received news of these recent events. Gasping. Sobbing. Roaring. Crashing. Crushing. Overtaking. Undertowing.

The former lifeguard in me recognized the drowning person’s combat, wordless and writhing under the weight of the wave of grief, struggling to keep her head above water, breathing in fits and spurts. Time is different in that space and place, seemingly at a standstill in the struggle to get to the surface, to figure out which way is up again. Until grief, finally deciding to subside… leaves the body limp and devoid of form or feeling, like seaweed tossed upon the shore both as an afterthought and as a reminder of the power of the wave that has (temporarily) receded.

I am still on this sober beach, lying on the sand in the ebb of the tide in the interim between my mother-in-law’s death and burial, her demise and our ceremonial remembrance of her. I am experiencing the void of losing her and the unbearable anticipation of the loss that I know is still coming – the next hard wave that will hit when I want to pick up the phone after work to pass the commute home in her company – only to realize that I will never be able to do that again. I am also in anguish about what I cannot see coming – how I will react to the funeral rites I will experience for the first time as a family member in Switzerland. I have attended funerals here before, but not for someone within my family.

Despite my full integration into this Swiss society I’ve called home for over a decade, the subtle differences in rites and rituals here contrast from those of my home Appalachian culture and signal my otherness, and aloneness, to me. Certain differences in the timing of things and in how the ceremony is performed are culturally and painfully dreadful to me, like skidding against hard rocks at the bottom of a crashing wave without choice or conceivable resistance to the process.

Thus, documenting my feelings, resonances, and imaged analogies while I am still in the throes of fresh grief will serve to remind me, the healer that is hurting, that it is important to let people feel what they feel, to ask them to describe their resonances in whichever directions their sensations take them, to explore what grief and loss mean to them and how it is expressed in their culture(s), and to bear witness to their pain and struggle without trying to fix what is ultimately unfixable.

I will sit with my pain and accept it as the old acquaintance it is, letting it accompany me on this voyage to the beach and home again in the full consciousness that the length of this journey is unknown and impressible. I will also bear in mind that, at some point, I will not remember it as vividly as I feel it in this moment, and I will try to take some small comfort in that. I will eventually be able to feel the warmth of the sun again, despite its continued shining. And, when I sit as a counselor with grieving families, I will not soon forget – and will never minimize – the impact of the roaring waves of grief that cover them until their seas eventually calm again, even if just temporarily.

Allen Frances on the DSM-5, Mental Illness and Humane Treatment

Where DSM-5 Went Wrong

Lawrence Rubin: I first became familiar with your work around five years ago when I was teaching abnormal psychology. So, I’ll start off by saying that you’ve had a very interesting professional evolution. You were involved in the preparation of the DSM-III series, chaired the DSM-IV task force, but then became a strident critic of its successor, the DSM-5. Were you as critical of the DSM-III and IV, as you were of 5?
Allen Frances, MD: Well, I worked on the DSM-III, and I was one of the conservative voices trying to restrict the enthusiasm for expanding diagnoses beyond what I thought would be reasonable. I did my best, mostly unsuccessfully to provide the check on what seemed to me to be an ever-expanding diagnostic system. For DSM-IV, we established very high thresholds for making changes. And it turned out that we included only two diagnoses from the 94 that had been submitted to us as suggestions. We told the people working on DSM-IV that they would have to prove with very careful literature, if you used data reanalysis in the field trials, that any change would do more harm than good. And when you have high standards, very few new innovations get included.So, my concern about DSM-5 was that the experts doing it were given just the opposite instructions; to take the diagnostic system more as a blank slate and to be creative.

And if I’ve learned anything during these 40 years I’ve worked on DSM’s, it’s that if anything can be misused, it will be misused, especially if there’s a financial incentive.

And pharma, the big drug companies, have a tremendous financial incentive in making sure that every DSM decision is misused by expansion, so that people who are basically checked well are treated as if they’re sick. They become the best customers for pills. And drug companies have become experts in selling the ill to peddle the pill. So, I was very concerned the DSM-5 would have the negative effect of opening the floodgates even further to what seems to me to be fairly wild diagnosing, excessive use of medication, especially in kids, but also in adults and geriatric populations.

LR: So get as many new diagnoses out there as we can; make money, comport with the drug companies.
AF: I think that’s a misunderstanding. The people doing this were not doing this as an effort to curry favor among the drug companies, although many of them had some connection, a financial connection with pharma. I don’t think that that’s the motivation that lead to the DSM-5 expansions. I think intellectual conflicts of interest are much more important, and much more difficult to control than financial. And the experts in the field are always in the direction of expanding their pet diagnosis. They can always imagine a patient they’ve seen, who couldn’t fit into the existing criteria, and they worried very little about false positives.They were much more concerned about missing a patient, than mislabeling someone who shouldn’t be diagnosed. I think the people working on DSM-5 were honest. I don’t think that they had any inclination to help the drug companies, but their own experiences as experts in the field don’t generalize well to average practice.So, if you’re working as a research psychiatrist on a very exotic condition at a university clinic seeing highly selected patients, having lots of time with every patient, using careful diagnostic instruments, you get an idea about what might make sense. That’s completely inappropriate for primary care practice, where most of the diagnosis is done, and most of the medication is prescribed. I think experts were making decisions that might be reasonable in their own hands, but that would be absolutely dreadful once used widely in general practice.

LR: So, just a seeming disconnect between the researchers in these rarefied atmospheres and those frontline folks seeing people day to day!
AF: Exactly. And I think that this goes for all manifestations; what we see in psychiatry is not at all special to it. That every single branch of medicine has an inherent systematic bias towards overdiagnosis. Recently, the new guidelines on hypertension resulted in something like 40 million additional people being called hypertensive.Guidelines should not be left in the hands of professional associations. They should be done by people who are neutral. And use experts, but don’t allow them to call the final shots

A Diagnosis Should be Written in Pencil

LR: Have you seen any discernible impact of your anti DSM-5 sentiments in the last five years since its publication? Has the field shifted back to listening to some of the concerns that you and others have had in terms of overdiagnosis and lowering thresholds?
AF: Yeah. And again, it’s not just psychiatry. This has been a problem in every single medical and surgical specialty. And there is an increasing chorus of Davids fighting the huge Goliaths. The huge Goliaths in this case are the drug companies and the professional specialty organizations who have vested interest. The medical industrial complex is now a $3 trillion-dollar industry. And it is most profitable when people who are basically well, feel sick, and get treatments they don’t need. And so, its tremendous budgets are expanded by the demand of all medicine in the direction of increasing patienthood and recommending ever more expensive treatments.The Davids fighting this are just a small group of people with very limited budgets, but sometimes right does make for might. And the medical journals in general have become much more aware of overdiagnosis. I’ll be at two meetings this summer, one in Helsinki, and one in Copenhagen, both focused not just on psychiatry, but across medicine and surgery on the topic of overdiagnosis. There’s an institute called the Lown Institute that’s working very hard to promote right care rather than excessive care. And there’s a wonderful initiative called Choosing Wisely, in which the various medical specialties are identifying those areas, where there’s excessive diagnoses and treatment.And I think in psychiatry and psychology, there’s been an increased realization that there are risks to diagnoses as well as benefits. And seeing any individual patient, it’s very important to adapt the general guidelines to that person’s specific situation, and to ensure that a diagnosis will be more helpful than harmful. It’s the easiest thing in the world to give a diagnosis. It only takes a few mindless minutes, and very often diagnoses are given precisely that way. Eighty percent of medication is dispensed in primary care practice, often after visits of less than ten minutes. A diagnosis once given, can have terrible consequences that haunt and last a lifetime.

And so, from my perspective, a diagnosis should be a very particular moment in a patient’s life. It should be, when done well, a very important positive moment.

A good diagnosis leads to feeling understood, to no longer having a sense of confusion and uncertainty about the future.  It helps the patient develop, with the doctor or the psychologist a treatment plan that may have a tremendous positive influence on their future. An inaccurate diagnosis carries unnecessary stigma and the likelihood of medication that will do more harm than good. And again, that haunting inability to ever get it erased. Because things evolve over time and people change from week to week, people usually come for help at their worst moment, and how they look at that moment may not be characteristic of their past or predictive of their future. I think it’s crucially important to take diagnosis seriously. A great way of putting this is a diagnosis should be written in pencil.

LR: I like that.
AF: Especially in kids.

On the Diagnosis of Children

LR: It seems that what you’re saying is that there’s this overt and covert attempt to enfeeble consumers. And you’ve written a lot online recently and seem really upset about what’s going on with children. Research seems to say that one in five are diagnosable, and one in 68 is on the autism spectrum. And you talked about stigma lasting a lifetime. Do you see that this is particularly the case when we hand out diagnoses to kids at very tender ages?
AF: First of all, never believe survey results that say one in X number of kids has the diagnosis. There’s an enormous systematic bias in all epidemiological studies. These are usually done by telephone, or by self-report, and they can never judge clinical significance. So, they’re only screeners that would at best provide an upper limit on the regular diagnosis, never a true rate but they’re not reported that way. And once it gets out, you know, it used to be that 1 in 2,000 or fewer kids had a diagnosis of autism. We changed that. One of the changes in DSM-IV was adding Asperger’s, which did dramatically increase the rate. But we expected the rate to increase by three times, not to go from 1 in 2,000 to 1 in 50, which has happened over the period of these last 20 years.And I think that some of that is identification of people who previously didn’t get the diagnosis and needed it, but a lot of it has to do with wild generalist diagnoses, and survey methods that are very misleading. I think that kids are very changeable, from week to week, and month to month. There are changes in development that are responsive to family stress and school stress, peer pressure. And what happens instead is we have wild overdiagnosis in attention deficit disorder and autism and this is done in a way that doesn’t respect the fact that these are young brains.We don’t know the impact of long term medication on the developing brain. It’s like a public health experiment that’s being done without informed consent. And all the indications for ADHD is that the beneficial results are short term. That academic performance over the long term is not positively impacted. That we should be a lot more cautious, both in diagnosis and in treatment, especially with young kids where diagnosis is so difficult, and where treatment may have negative as well as positive impacts. The most dramatic example of this is attention deficit disorder. There are five studies in different countries with millions of patients – not millions of patients, but millions of kids –and these have found that the best predictor of getting a diagnosis of ADHD and being treated for it with medication is whether you’re the youngest kid in the class. The youngest in the class is almost twice as likely to be diagnosed and treated than the oldest kid, which is clear cut proof positive, slam-bang evidence of overdiagnosis. Their immaturity is being turned into a disease, and kids are being treated with medication for basically just their immaturity. And the fact that the classrooms they’re in are too chaotic, and don’t have enough gym time, and don’t have enough individual attention.

LR: A woman wrote a chapter for one of my books, Mental Illness in Popular Media, on the use of adenoidectomies and tonsillectomies in the early part of the 20th century to deal with the seeming epidemic of kids who would today be diagnosed with ADHD. There seems to be this history of medicalization of childhood that you’re alluding to, and this perverse need we seem to have to enfeeble kids. And if anything, it seems that it will keep them more dependent, less productive, and less competent than ever before-an unintended side effect.
AF: I was one of the kids, who might have gotten the tonsillectomy.
LR: Me too.
AF: I remember that well. My father said “no, we’re not going to do that,” but the doctor recommended it, and all the kids on the block had gotten tonsillectomies. Medical diagnosis and treatment tends to run in fads. Over the course of history, there have been diagnoses and treatments that have sudden runs of popularity that now seem absurd. And some of our practices today will seem very troubling when looked at in the coming decades.
LR: Do you see Disruptive Mood Dysregulation Disorder (DMDD) as being part of this fad bandwagon? And even though it’s got this fancy name, it’s still considered child bipolar disorder, and that’s really damming.
AF: What happened here was really nuts. There had been suggestions by psychiatrists heavily funded by the drug industry to include the child version of bipolar disorder in DSM-IV. And we rejected those suggestions, fearing that it would lead to a tremendous overdiagnosis of bipolar disorder in kids. Despite our rejection, the diagnosis suddenly became popular, partly because the drug companies finance these guys to go around the country giving conferences and partly because child psychiatrists can sometimes be very gullible. And very young children, even infants were getting antipsychotics for a fake bipolar disorder diagnosed in the early years of life. The field of child psychiatry became concerned about this and wanted to correct it, but the fix in DSM-5 was exactly wrongheaded. What should have been done is a black box, a warning in DSM-5 about the overdiagnosis of childhood bipolar disorder. And the caution that the kids should be seen carefully and over long periods of time, and that they should meet criteria before a diagnosis of bipolar was made.
LR: A black box warning?
AF: There should have been a warning about the dangerous fad. Instead, they substituted a new diagnosis that essentially is childhood temper tantrums, hoping the kids who previously had been mislabeled bipolar would get this lesser diagnosis instead, lesser because it wouldn’t imply the need for mood disorder medications that would imply a lifelong course. But why substitute a new diagnosis for temper tantrums that can be so easily misused.The system tends to accrete, rather than to sunset diagnoses. It tends to always be adding new things, rather than warning about, or eliminating things that are already in the system that may be dangerous. So, parents have to be very well-informed about their kids.

LR: And they’re not.
AF: And the concern often is, if I don’t get my kid a diagnosis, say of ADHD and medication, he’ll be behind in school. I think parents have to have the opposite concern, as well that the medications are being given out way too loosely, and they need to protect their kids from medication that may not be needed.That said, I get more criticism, from people who feel I defend medication too much. I’m absolutely convinced that medication is useful, when given carefully to the few. That it becomes harmful only when it’s handed out carelessly to the many. And the people who go in either direction, either blindly supporting the use of medication, or blindly opposing it, I think of both as extremist, and they do harm to the real needs of the people. But there will be, and are, a large number of people who need medication and can’t get it, either because of inadequate resources or problems with financing treatment. And we have to worry about the people who are neglected very much. At the same time, we have to be mindful of the fact that we have the paradox of over-treating people, who are basically well, while we’re neglecting those who are really in need and desperately unable to get the treatment that would be helpful for them.
LR: You wrote a blog post titled, “Please empathize with me, doctor!” And from what you’re describing Allen, it seems that we are struggling with a societal empathy deficit disorder. There seems to be a preference for scientizing our relationship with kids and with our patients at the expense of understanding, at the expense of taking the requisite time. And at the really painful expense of not empathizing with these people, who are just going to be tossed into the system with labels and scripts. Empathy deficit disorder, maybe it will be in DSM-VI, or DSM-2.0.
AF: We could use it for our president.
LR: We’ll save that for later.
AF: Actually, the issue goes all the way back to Hippocrates, the father of medicine 2,500 years ago.

But First, Do No Harm

LR: Do no harm.
AF: Do no harm. He also said that it’s more important to know the patient who has the disease, than the disease the patient has. I don’t trust clinicians who only do DSM check lists. They don’t know the patient. I don’t trust clinicians who don’t know DSM and do free-floating evaluations that don’t take into account the ways that the individual may have a problem that’s been well described and has a set of guidelines that will be very helpful. I think that every clinical encounter needs to be a combination of close person-to-person collaboration, that the DSM guideline should never be applied blindly to each individual because they vary within themselves. It has to be customized for that particular person’s own situation. At the same time, not knowing the DSM diagnoses is likely to result in missing things that would be crucially important in treatment planning.
LR: False negatives.
AF: Good interviewers are people who are able to form great relationships with their patients, work collaboratively in understanding the diagnosis and planning a treatment and able to use the DSM without worshiping it.
LR: It seems that what’s needed, as you say is more time, a deeper understanding and a reluctance to jump into a diagnosis. This seems antithetical to the way that psychiatry and even psychology are practiced today. And clinicians are under more and more pressure to assign a rapid diagnosis and develop a treatment plan within the first session or two. What advice do you have for clinicians who are under this type of pressure, and may not have the luxury of flexibility and time that we know is necessary?
AF: Well, first-off, the system is crazy. Insurance companies do this because they think it will restrict costs, but it has the perverse effect of forcing people to make premature decisions that often will result in more costly treatment. Giving a person a medication is likely to create a commitment to see that patient over a long period of time. Diagnosis can increase the lifelong cost of taking care of that person. If the insurance companies gave more time for evaluation, many, many of the problems that get a diagnosis and long-term treatment would pretty much go away on their own with time and simple advice.The system is counterproductive; the more time we spend upfront with people in the evaluation process, before diagnosis and before treatment, the fewer diagnoses will be necessary, the less lifetime treatment will be needed. And it will actually be much more cost effective to give people time to get to know the situation at the beginning. I think for practitioners, it’s important always to underdiagnose. That it’s crucial to first of all rule out the possible role of medication and symptoms. You know, very often, hundreds and hundreds of times in my career, new symptoms have been due to medication.
LR: Iatrogenic?
AF: The average person over 60 to 65 is taking five, six, seven pills. Recent studies showed how many of them have depression and anxiety as side effects. And the older people particularly are less able to clear medications. So, you have a combination of a bunch of medications that can cause side effects, and a person not being able to clear those medications. And new symptoms are often treated with yet another medication, rather than realizing it’s a side effect. I think that it’s important to rule out medications. It’s important to rule out substances. It’s important to rule out medical problems. That has to be done during the first sessions. I think that’s crucial. But beyond that, I think it’s important not to jump to lifelong diagnoses based on very limited information. And to tend, at the beginning at least, to normalize, rather than to pathologize the situation.We see people on the worst days of their lives and tend to draw conclusions about them. And their futures are often inaccurate. They look very different days and weeks later.

Mind, Body or Both

LR: How can the average psychotherapist develop a healthier relationship with the biopsychosocial model? I know you said, you have to look for substance abuse. You have to look at the iatrogenic effects of medication. You have to look at the psychotropics that they’re on. So, how does the average psychotherapist, who is not particularly savvy when it comes to psychotropics, really have a full biopsychosocial understanding of these complex organisms that are people?
AF: I think one of the great losses over time has been the biopsychosocial model, particularly because of the mindless warring between people who have narrow views that are biological, or just psychological, or just social. I think that it’s impossible to understand the complexities of human nature and of how we function and dysfunction without taking into account the biological, the psychological, and the social, and sometimes there’s spiritual issues that people come with. And I think it’s just as important that psychiatrists be good psychotherapists and understand the way that social pressures result in symptoms. And it’s equally important that psychologists understand diagnosis and also the use of medication. Even if you’re not prescribing it, it’s very important to understand when to and when not to use medication. If for no other reason, to make sure the patient’s not getting too much medication, as well as knowing when to refer. I think every clinician needs to be complete. I don’t think that training in one discipline gives permission not to be aware of the tools that are available more widely across disciplines.
LR: Do you think there’s such a thing as a psychosocial reductionism? I know there’s biomedical reductionism. Do you see a danger at the other end of the extreme, of psychosocial reductionism?
AF: Oh, definitely. Psychosocial reductionism, yeah, it’s alive and well, particularly in Britain where there’s an ongoing back and forth. An active segment of British psychologists has taken a pretty radical view that psychosis is on a continuum with normal. That biological elements have been way over-emphasized in schizophrenia. And that most of the problems patients present have to do with childhood trauma. And again, every point of view has value, but no one point of view is necessary and sufficient.
LR: There are many truths. There’s just as much psychosocial reductionism as there is biological reductionism in many of these debates. You know, talking about biomedical and psychosocial reductionism, I remember when, around the time that DSM-5 came out, NIMH really took a stand and said, “Yeah, nice work boys and girls, but we’re going to pretty much move to the RDoC.” A lot of psychotherapists practicing day to day, who don’t work in academia, don’t read a lot of the scholarly journals, don’t have the bloodiest idea of what the Research Domain Criteria is. Do you see that system as useful or valid? Specifically, how useful do you see it in alleviating some of these ills of overdiagnosis and wrongheaded treatment?
AF: Well, the DSM had tremendous promise as a research tool, but it’s failed in that the complexities of brain functioning, of genetics, have been so enormous, the more we learn, the more we realize how little we understand.The brain is the most complicated thing in the known universe. It reveals it secrets very slowly.  And it turns out that there are hundreds of genes involved in schizophrenia and every other psychiatric disorder, not just a few. And all of the neuroscience research has been remarkably productive. One of the great intellectual adventures of our time is the research that’s been done on how the brain works; however it hasn’t helped a single patient!

I think we have to be aware of the fact that there are no low-hanging fruits. That we’re not going to have breakthroughs that will explain schizophrenia or bipolar disorder. That each of these conditions is probably hundreds of thousands of different conditions that share some clinical features, but probably have very different biological underpinnings. And we shouldn’t be so dazzled by the science that we lose track of taking care of real patients in the present. I think there’s so much promise, so many high promises in the future, and our NIMH budget is being spent almost exclusively on basic science research, almost not at all on clinical research, that we’re ignoring the needs of patient today.

To me, it’s a tragedy that we have 350,000 patients in prisons, and 250,000 homeless on the street that we’re taking minimal care of, we’re neglecting people desperately in need. And that most of the research has its head in the air trying to find out things that maybe are going to be helpful to a tiny percentage of patients in the future. Meanwhile, we know how to take care of people now, we’re just not doing it.

We’re not making the investment in community treatment, housing, recovery programs, that would be necessary to eliminate the shame on our country. Almost every other developed country takes much better care of their mentally ill than we do. The U.S. is the worst place in the country to be severely ill. And it’s not a matter of neuroscience or science in general, it’s just the common sense, practical taking care of people and treating them as citizens, not neglecting them. And what we do in this country is provide almost no funding for community treatment and support

LR: It goes back to this idea of empathy deficit disorder. You talk about science, I like the point you make about the RDoC. That it’s a magnificent academic tool, but maybe in the year 2635, we’ll find a gene for some component of bipolar disorder, but how many people are going to struggle and lose their lives before that?
AF: And I don’t think we will find the gene. I think what we’ll find, it’s like breast cancer, we’ll find that there are certain genes predisposed in a very small percentage of the people who have the disorder. And that’s the complexity. There’s a paper that came out that had 250 authors that found 105 genes for schizophrenia, each of them a tiny bit different than normal. And the permutations and combinations of those genes would be astronomical. What that says is that the complexity of these disorders is so great that there will be no simple answers. In the meantime, we shouldn’t be allowing people to not have treatment and not have housing and to wind up in jail. And the resources, the techniques, the ways of preventing this, of making our country less of a shameful outlier in how we treat the mentally ill are perfectly obvious, it’s just a matter of funding and political will. And the severely mentally ill are the most disadvantaged, the most vulnerable population in our country.

It is the Relationship That Heals

LR: I find a bizarre paradox in all this. When I think of psychosocial treatment, I think of the amount of money, time, resources, the human capital, that’s being spent to develop these empirically supported treatments, and ultimately you end up with cognitive behavior therapy at the top of the heap. There seems to be this manic pull in psychology and psychotherapy to develop empirically supported treatments, which many argue take the heart and soul out of the human connection, out of psychotherapy. Do you have any thoughts about this scientific perversion and how it’s affected the field of, and the practice of psychotherapy?
AF: I don’t think it’s so much scientific perversion. I think it’s economic pressures; that every therapy wants to gain a list of insurance companies who will pay for it. And this leads to a kind of competition to prove that your work is validated. I’ve been following this field now for 40 years. I was on the NIMH committee that used to fund psychotherapy projects that no longer exist, of course, because of NIMH’s current focus on the brain. But the overwhelming finding in the literature is that all of – this is a paper that was published 40 years ago by Lester Luborsky – all have run, all have won, and all deserve prizes. That all psychotherapies can be helpful. More of the outcome, of the variance in outcomes is returned by the therapist through a client relationship, than it is by specific techniques. That it’s kind of silly to have a competition amongst therapy techniques because all are necessary.I think to be a therapist, you should be well-versed in every single type of therapy, because patients vary between, and also even within themselves and what they need in a given moment. And it’s not as if one, as if cognitive techniques are inherently better than techniques that focus on psychology or the social situation. Different techniques are going to be different at different moments. And the technique in general is useful only in the context of a relationship that’s nurturing and healing. And the most important thing in the healing of psychotherapy is probably the nature of the relationship, and the need for a personal match between the two people. I think that it’s been an unfortunate – there’s been an unfortunate tendency to develop competitions. Competitions between medications versus psychosocial approaches. Competitions among the various psychotherapy techniques.A really well-rounded clinician has to be good at everything, and especially has to be good at relating to the people that they’re trying to treat.

LR: I have to tell you Allen, it’s refreshing to hear a medical man, a psychiatrist in particular, especially one who is that connected to the history of the DSM know about the Dodo effect, and to really appreciate that. So, you have the average therapist working in the average practice in a community mental health center, maybe even in a homeless shelter, recognizing that the technique is not nearly as important as the relationship. And then they come across a client, who seems psychotic in the moment, or seems to have a history from limited information of bipolar disorder or schizophrenia, and their knee-jerk reaction may be “I have to get this person to a psychiatrist. I have to find out what’s medically wrong with them.” What does that average line worker do, knowing in their heart that their relationship is critical, but that they have this biomedical pressure to refer to a psychiatrist, or even a primary care physician?
AF: Well, I think everything is important. You mentioned primary care physicians. People with schizophrenia die 20 years earlier than the rest of the population. And that gulf has increased in recent years and is much higher in the U.S. than it is in other country, because we neglect the people so much. There isn’t one answer.

Taking it to the Streets

There’s not one size fits all. And there isn’t one answer to people who have tremendous problems at every level. I mean, the first thing with a homeless person might be sharing some orange juice. It’s forming a relationship. It’s finding out a way where they can have housing. It’s not as if the answer to our blanket neglect is going to be getting an appointment once a month with the psychiatrist and getting a pill. That may be a necessary part of the plan, but certainly won’t be sufficient.

Los Angeles is now embarking on what may be the most encouraging experiment in taking care of the severely mentally ill that I’ve seen in this country in the least 40 years. It will be an approach that will be actually a combination of getting out to where the people are who need help, figuring out what they want, and helping them get it. You know, maybe the first step is providing showers, and a welcoming environment, and a place to have lunch. And the housing is going to be probably more important than treatment.

If you can’t get someone a decent place to live, the rest of the treatment is going to be very hard to carry out.

We have to figure out a way of getting the patients out of prisons and getting the people on the street into decent places to live. We had all of this until the Reagan Administration in 1980. The community mental health centers and housing were an increasing and exciting part of the care. We led the world in the ‘60s and ‘70s, in trying to devise community treatments. And now we are at the very bottom of the pack, one of the most heartless places in the world. One of the worst places in the world if you’re mentally ill. It’s not going to be a solution that takes into account just one need. It’s going to have to be a kind of total approach that includes the police, the sheriffs, the prisons, the district attorneys, the judges and the politicians. And that’s exactly what’s happening now in Los Angeles, and that may serve hopefully as a model for the rest of the country.

LR: As a psychotherapist, I listen to the inflections and the changing tone in your voice. And there’s such enthusiasm and energy when you talk about all that can be. And there’s a discernible lilt in your voice, almost a down-turning in your overall demeanor when you talk about the way things are.
AF: I think one of the things that’s crucially important to understand is that the symptoms we see in the very ill aren’t necessarily inherent to their condition, but rather maybe a reaction to the social context in which they’re living. The example 60 years ago was we kept people warehoused in terrible snake pit state hospitals. And the observation was that the hospitals were making them sicker, because of the social neglect within in. What’s happening now in the United States is that by neglecting people and leaving them without treatment and without housing on the street, we see much sicker patients here than in other countries that provide better care.So, the paradigm of good care here is Trieste. And I’ve heard over many years, how wonderful the Trieste system was in treating the severely ill, without hospitals, without restraint, and with minimal medication, but not the high doses and multiple medicines that are given in the United States. And I never believed it until I visited. And now I’ve been there three times over the last five years, and it’s an absolute miracle. Trieste takes good care of the people with severe mental illness and treats them like citizens. It has social clubs for them and a career path. The Trieste Mental Health System runs two hotels, five cafes, a car service, and a landscaping business, so that people who start out as patients, wind up working in the system. They have housing. They take good care, and they treat people with respect. And their patients are a lot less sick than ours.They just don’t get to the levels of psychopathology that we see in this country because there’s such neglect along the way. And the message in this is, treating the casualties, the train wrecks, is a lot more expensive and heart breaking than doing the right thing at the right time, earlier in the course before the illness progresses. I think there is a tremendous shame as a civilization that what we’ve done is fail to provide.

Ever since the Reagan Administration, we’ve failed to provide community housing and community treatment, rehab, and recovery. And instead we hospitalize hundreds of thousands of individuals in prison.  We’ve imprisoned hundreds of thousands of individuals, who should be in community programs, and maybe very occasional inpatient stays. We see them on the street every day and I just pass them by. My hope is that Los Angeles will be a beacon that things can be different.

LR: Is the Trieste system similar to L’Arche?
AF: It actually started in the ‘60s, with the closing of the large mental hospitals in Italy. And the system is based on the idea that everyone can be helped, everyone’s a citizen, everyone deserves respect, and that the community funds adequate social programs and treatment programs, and housing programs, and job programs. And they make the assumption that each person can be a useful citizen in the community. And when people get sick, instead of throwing them in a hospital and keeping them there for a long time or throwing them into prison which is what we do, or instead of keeping them on the street, there is tremendous concern for them and individual attention for them in figuring out a way back to health. And it just works. It’s miraculous. And people don’t ever get as sick as the people we see on the streets and in our prisons and our emergency rooms, because they’re treated with respect and care.

Reaganomics and Mental Health Care

LR: What do you think happened back in the Reagan era that directed us away from compassion, and away from potential? What happened?
AF: I mean, it’s very clear, this history couldn’t be more explicit and disheartening. The Kennedy Family, because they had mistreated one of their family members, had a huge personal interest in this themselves. In the ‘60s, there was the first use of medications to help people who were previously hospitalized to live in the community. And there was a bill, the Community Mental Health Center Bill that established all across America, the notion that we could help the individuals better in the community than by warehousing them in state hospitals. The money was meant to come from the state hospitals, so it seemed like and was a tremendously cost-effective transformation that we would close the state hospitals, and instead spend the money on community services and housing. And with the provision the medication people could be managed, creating for them to live much better lives outside of hospitals than within, and it would be cheaper.All of this was working. I worked in places in the ‘60s and early ‘70s that were quite remarkable in helping people find new lives outside the hospital. What Reagan did in the ‘80s was to send block grants, and this should sound familiar because it’s exactly what Trump wants to be doing now. Instead of providing federal support for these programs, Reagan said we’ll take this money and send it back to the states and them let them spend it the way they want to spend it. And what the states did almost uniformly was either use the money to reduce taxes, or use the money for other priorities or general funds. And the community mental health centers were gradually defunded and privatized. And private systems will never take care of the severely ill, because they’re expensive to take care of. So, the community mental health centers that survived, did so by restricting themselves to healthier patients, who had more money and fewer needs.And some went out of business altogether, some switched into behavioral health centers, treating people who were much healthier and neglecting those who were really ill. So, what we did in the ‘80s was destroy what in the ‘60s and ‘70s was the most innovative and one of the most effective [community mental health] systems in the world. The rest of the world continued to care for the mentally ill in a much more humane way, and it gets much, much better results. And the paradox in the states was that with the closing of the community mental health centers, many of the individuals untreated on the street committed petty crimes and sometimes not so petty crimes that resulted in their being in prison. And we’ve had this tremendous increase in the number of prison beds so that the LA County Jail is the biggest psychiatric facility in America. And in many states, the biggest psychiatric facility is now a prison. That the money that should have been spent on community treatment that had been spent on snake pit hospitals is now spent on prisons, and there’s kind of prison industrial complex that keeps that going.

LR: So, it’s a reactionary swing back to the early part of the 20th Century, when criminals and the mentally ill were merged. And a misappropriation of funds.The Republican agenda to decentralize the federal government, combined with various historical, sociological and financial factors, and these poor people were and are just caught in the crosshairs.
AF: Yeah, until the early 1800s, psychiatric patients were criminalized, along with prisoners and the poor in horrible facilities. The father of psychiatry is Pinel. And in the early 1800s, he freed the patients from the chains, treated them like decent human beings and citizens, and got remarkable results. And that led to the state hospital movement which was originally a positive movement…
LR: A community.
AF: Yeah, gave people a place to live and work. And they usually had farms, they had workshops. And it was only if these became overcrowded in the early parts of the 20th Century, that they turned into snake pits and asylums. That led to the deinstitutionalization movement that began in the late ‘50s and early ‘60s. And it led to a community mental health center movement that was really quite encouraging and effective in the ‘60s, ‘70s, and early ‘80s. And that was pretty much destroyed from the mid ‘80s on. And at this point, we have very few effective community mental health center initiatives in our country, and we have lots of prisons treating the mentally ill, and the mentally ill on street corners in all the major cities.
LR: A reactionary swing back to the past.
AF: Privatization doesn’t work. I mean, if we’ve learned anything about healthcare, mental healthcare, and healthcare in general, it is that a for-profit system will result in way too much treatment for people who don’t need it, and way too little treatment for the people who do.
LR: So, we need psychotherapists out there as social workers more or less. Maybe more training at the graduate level, at least in psychology and counseling in the direction of community mental health and social advocacy.
AF: In all of the mental health fields, there’s been way too much attention to treating the easy patient and the well-paying patient, and way too little of taking care of the people, who really need our help. And I think that the most wonderful experiences of my life have been the saves of people who seem to be beyond saving. And anyone can treat someone who doesn’t really need treatment.
LR: Right.
AF: We should be trying to focus our attention on those who really need us.

The Twilight of American Sanity

LR: We’re sort of winding down and I wanted to ask about this irrepressible current in you…about the impetus for writing Twilight of American Sanity: A Psychiatrist Analyzes the Age of Trump, and what you think is going on in government and in our society? I see Trump as a symptom rather than the disease, but would you mind talking about what you think is going on, from a psychiatric, psychological point of view?
AF: I started writing the book well before Trump began running for office. I’m concerned for my children and grandchildren, and the future generations more generally, about the fact that our society was delusional in ignoring global warming, overpopulation and resource depletion. And a bunch of other problems that are so obvious and common sense just sliding right by, as if we can hand on to the next generation a world that’s degraded and dangerous. And so that was before Trump. Trump is a mirror to our soul and the reflection ain’t pretty.And he is a symptom, not the cause, but he’s certainly making the disease much worse. I think there has never been a threat to American democracy like this one since 1860. And this election, this midterm election is to me the third most consequential election in the history of our country, the other two being 1860 with Lincoln’s election, and 1932 with Roosevelt. I think that Trump is a direct danger to our democracy. His attack on the free press, on the court systems, on the institutional checks and balances is not a joke. And that at this point, the sides are fixed. I don’t think either side is going to give into the others. And I think the crucial thing will be the vote, getting out the vote. And anyone who cares about this country, and cares about – I think that Trump could be responsible for more deaths in the next century than Hitler or Stalin and Mao combined. I think global warming is an existential threat to our species. And that we don’t know where the tipping point is, but we’re likely approaching it without taking out an insurance policy.People in their individual lives have insurance policies even though they don’t expect to die tomorrow, or have a fire, or an accident, you just protect the future. And we’re tripping over the cliff of global warming without taking an insurance policy for our kids and grandkids, that the world will be livable for them. I feel a sense of despair if our country is not able to right itself. And it was a wonderful thing that we were able to elect a black president ten years ago. It will be a much worse horrible terrifying future if at this point we re-elect the people who have been willing to give Trump such a wide leeway in destroying our country and our world.

LR: Well said. I think that we have a responsibility as therapists, as mental health clinicians to be aware of what’s going on because many of our clients are the day-to-day recipients of some of the changes in policy that are being created. I think psychologist, psychotherapists, psychiatrists, need to be politically aware without becoming politically depressed.
AF: I think it’s important not to be psychologically name-calling Trump. Thinking of Trump as crazy, tremendously underestimates his evil and cunning. We have to fight Trump with political tools, not with psychological tools. I think as therapists, we need to help most of our patients – I think you can’t politicize treatment.And so, a good therapist should be able to treat someone who is a Trumpists and should not try to get into political discussions with their clients and patients. I think as citizens, it’s an important thing for every therapist who cares about the social safety net of our country. The biggest factors with mental illness don’t come from within psychology and psychiatry. The biggest factors of mental illness come from social forces.Inequality or poverty are tremendous drivers of mental illness. I think it’s a responsibility for therapists to be political, not in calling Trump names but rather in getting out the vote. There’s the Kansas thing and getting their friends to register, getting their family members to register. Because I think everything has to do at this point with the numbers of people who show up in November. And I think there may be some therapists who support Trump, it’s hard to imagine, but by and large, most therapists and most people they know will be on the side of trying to protect democracy and protect our environment. And so, I think the most important thing a therapist can do at this point is to help get out the vote.

LR: Do you think mental health treatment and funding for mental health at the community level is in danger, with this and similar administrations?
AF: Oh, yeah, Trump recently, yesterday, there was a news report that what the Republicans are going to try to do to cut Obamacare is to cut out the [mental health] parity elements in plans.
LR: All that work! All that work!
AF: And the Medicaid funding of the original Trumpcare bills was to do block grants, rather than to be supporting mental health, which is exactly what Reagan did.Our patients are being targeted by the irresponsible GOP Congress and by Trump.

LR: We don’t want to end this conversation on a depressing note.
AF: Well, the good news is that things are flexible, and that ten years ago we elected a black president, two years ago we elected a black-hearted president. And the country is fickle, and things are very much in the balance. And it is conceivable to me that we’re heading down the drain to a fascist autocracy. And billions of people dying in global warming in the next century. It’s also conceivable to me that there are fixers, and that this is a temporary worst moment and things have to look better. And really, I think it’s in the hands of who votes in November.

The Relationship is All

LR: I guess this is sort of a summary question – if you were to look back and advise a younger Allen Frances, what advice would you have given him early on his career that might have changed his direction, or are you pretty content the way it’s played out?
AF: It played out mostly by accident, and then it’s just doing your job. I don’t think that there’s – I think, there’s actually one advice to people; it’s listening to the clients/patients you’re working with and learn from them.
LR: They’re our best teachers if we let them.
AF: And be yourself. You can learn everything, but also be yourself.
LR: It’s refreshing, again coming from a psychiatrist, just on a personal note, my brother is a psychiatrist, retiring at the end of this month after 40 years. He’s cleaning up his slate of 350 patients. And I wonder what it will be like for him as he looks back on his career. How many did he help, and which ones stand out. Do you have any one particular client story that inspires you?
AF: I think this is the most telling thing, and this might be helpful to people. That I’ve treated people for 14 years and had no impact on their lives. I’ve worked in emergency rooms my whole career. And I’ve seen people for five minutes and they’d come back years later and said, you said that and it changed my life. You never know when what you say may have a tremendous impact on someone. And so, every contact with every person you see, at every moment, you should be thinking about what can I say that may make a difference. And if you treat people as humans, then every moment can be potentially impactful, not every pill, not every symptom, not every diagnosis. I guess the core message in our conversation has been that you really have to focus on the person.I mean, the two words that have had the most impact on people that I remember over the years is “do it,” because people would come in concerned, should I do this, or should I do that? I just say “do it.” And somehow at that moment it crystallized their energy and their motivation to do something that they wanted to do. We shouldn’t be shy in trying to figure out what it is that might help someone do something they couldn’t do.The relationship is all.